| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.053 | 0.6 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |